Is this you? Create Your Porfile
Avatar

David T MacLaughlin

Cornell University

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David T MacLaughlin is active.

Explore More

Publication

Featured researches published by David T MacLaughlin.

The Journal of Clinical Endocrinology and Metabolism | 1990

An immunoassay to detect human mullerian inhibiting substance in males and females during normal development

Peter L. Hudson; Dougas I; Patricia K. Donahoe; Richard L. Cate; James Epstein; R B Pepinsky; David T MacLaughlin

Development | 1999

The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo

Zhenyu Gu; E. M. Reynolds; Jihwan Song; Hong Lei; A. Feijen; Lian Yu; Weiwu He; David T MacLaughlin; J. Van Den Eijnden-Van Raaij; Patricia K. Donahoe; En Li

Archive | 2001

Delivery of therapeutic biologicals from implantable tissue matrices

David T MacLaughlin; Joseph P. Vacanti; Patricia K. Donahoe; Peter T. Masiakos

Biology of Reproduction | 1989

Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.

Vicki N. Meyers-Wallen; Mary M. Lee; T. F. Manganaro; T. Kuroda; David T MacLaughlin; Patricia K. Donahoe

Archive | 2008

Methods to identify and enrich for populations of ovarian cancer stem cells and somatic stem cells and uses thereof

Patrick Donahoe; Paul P. Szotek; David T MacLaughlin; Rafael Pieretti-Vanmarcke; David Dombkowski; Frederic I. Preffer

Biology of Reproduction | 1991

The critical period for mullerian duct regression in the dog embryo.

Vicki N. Meyers-Wallen; T. F. Manganaro; T. Kuroda; Patrick W. Concannon; David T MacLaughlin; Patricia K. Donahoe

Proceedings of the National Academy of Sciences of the United States of America | 2005

Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model

Vandana Gupta; Jennifer L. Carey; Hirofumi Kawakubo; Alona Muzikansky; J. E. Green; Patricia K. Donahoe; David T MacLaughlin; Shyamala Maheswaran

Archive | 1994

Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression

Patricia K. Donahoe; Tai Wai Chin; Robert L. Parry; James Epstein; Richard C. Ragin; David T MacLaughlin; Edward M. Barksdale

Clinical Cancer Research | 1995

Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.

M S Kurian; R S de la Cuesta; Gerald L. Waneck; David T MacLaughlin; Patricia K. Donahoe

Journal of Biological Chemistry | 1994

Modulation by sphingolipids of calcium signals evoked by epidermal growth factor.

Peter L. Hudson; W A Pedersen; W S Saltsman; M Liscovitch; David T MacLaughlin; Patricia K. Donahoe; Jan Krzysztof Blusztajn

Explore More

Collaboration

Dive into the David T MacLaughlin's collaboration.

Top Co-Authors
Avatar

Patricia K. Donahoe

Georgetown University Medical Center

View shared research outputs
Top Co-Authors
Avatar

Henry L. Chang

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Frederic I. Preffer

Harvard University

View shared research outputs
Top Co-Authors
Avatar

James Epstein

Harvard University

View shared research outputs
Top Co-Authors
Avatar

David Dombkowski

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Paul P. Szotek

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Rafael Pieretti-Vanmarcke

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Richard C. Ragin

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Peter L. Hudson

Harvard University

View shared research outputs
Top Co-Authors
Avatar

T. F. Manganaro

Cornell University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge